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Abstract
Identifying direct links between gene pathways and clinical endpoints for highly fatal
diseases such as cancer is a formidable task. Integrative analyses play a crucial role
in modeling these links by relying upon associations between a wealth of intermediary
variables and genomic measurements. Motivated to harness phenotypic information
about tumors towards a molecular characterization of low-grade gliomas, we develop a
data driven Bayesian framework to define sharp models, and calibrate accurately and
efficiently uncertainties associated with the promising biological findings.
The Bayesian methods we propose in the article (i) are amenable to a flexible class
of adaptive models, determined via a complex interplay between signals sifted from
variable selection algorithms and domain specific knowledge; (ii) have the advantage
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of computationally efficient high dimensional inference due to a focus on sharp models
with fewer parameters, when compared to their non-adaptive counterparts; (iii) exhibit
a significantly better reconciliation between model adaptivity and inferential power
than state-of-art approaches, when constrained by the curse of dimensionality. Our
main workforce involves a carefully constructed conditional likelihood and utilizes a
reparameterization map to obtain compact formulae for a selection-corrected posterior.
Deploying our methods to investigate radiogenomic characteristics for diffuse low-grade
gliomas, we successfully uncover associations between several biologically important
gene pathways and patient survival times.
1 Introduction
Modeling links between genomic variables and clinical endpoints, followed by evaluating the
strengths of promising associations provide key insights into the etiology of many diseases.
However, uncovering direct links between the genomic triggers and important clinical re-
sponses often turns out to be a highly prohibitive task in the case of critical diseases like
cancer (Mazurowski, 2015). With multiple modalities of information produced across differ-
ent technologies, present day modeling pipelines increasingly rely upon integrative analyses
to harness associations with a wealth of intermediate variables (Lambin et al., 2017, for ex-
ample). These findings are then used to define plausible biological models for fatal diseases.
In the specific context of cancer, previous investigations (Kim et al., 2010; Network, 2015;
You et al., 2016, among others) have demonstrated the role of imaging data as a mineable
intermediary phenotype resource to successfully discover correlations between genomic mea-
surements and patient outcomes. Given the driving motivation to effectively explain the
variability in patient outcomes at the molecular level and infer accurately about the effect
sizes of potential biological underpinnings, the current article develops data driven Bayesian
methodology with two significant contributions.
A foremost highlight of the proposed approach is that it aligns along a much needed flex-
ible framework for data driven modeling. The number of potential parameters in integrative
investigations of critical diseases overwhelmingly exceeds the number of matched samples
across intermediate and explanatory variables. Meaningful, sharp and scalable models rep-
resentative of variability in patient outcomes are defined in these scenarios only after solving
powerful variable selection queries (Hastie et al., 2000; Brzyski et al., 2017; Qian et al., 2019,
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among others). Complementing the necessity of model adaptivity to data-sifted signals, the
ability to incorporate existing biological knowledge into models is often needed to impart
clinical meaning to the resulting findings (Stingo et al., 2013; Zhang et al., 2019). Addressing
therefore the need of pliable modeling, the current article proposes a Bayesian workforce to
infer using data driven models. Imposing almost no restriction on the nature of interactions
between the variables selected by regularized algorithms and existing domain information,
our methods crucially allow this synergy to be black box in principles.
A second focal point of our methods is that they strike a significantly better reconciliation
between model adaptivity and inferential power than state-of-art inferential strategies. This
is an inevitable tradeoff when available data must be allocated for modeling and inference.
Particularly after the formulation of data driven models, a daunting challenge in the core task
of uncertainty calibration is posed by a serious loss of inferential guarantees. Underscored in
literature (Benjamini and Yekutieli, 2005; Berk et al., 2013; Lee et al., 2013; Yekutieli, 2012)
as the effect of a winner’s curse, statistical estimates suffer from selection bias due to a naive
reuse of data samples during inference, that were also deployed for a model hunt. Inference
using sparse data driven models, mined from a high dimensional set of genomic variables
are a perfect exemplification of this conflict in the use of data for adaptive modeling and
reliable inference. A popular strategy to overcome this bias is a tradeoff in data towards
modeling and inference, introduced by a splitting of the data samples at hand (Hurvich and
Tsai, 1990, see for example). In a conceptual framework of conditional inference (Lee et al.,
2013; Panigrahi et al., 2016; Tian and Taylor, 2018; Panigrahi, 2018), the methods in this
paper enable a reuse of data from the model selection stages. This allows us to achieve a
better balance in information which results in a larger number of true discoveries with higher
inferential power.
The main contributions of the present article involve 1) the construction of a carefully
chosen conditional likelihood; 2) a crafty deployment of a reparameterization map to sam-
ple from a transformed space. Both the steps are integral to deriving compact analytic
expressions for a scalable posterior that counters the effects of winner’s curse. The strategic
choice of the likelihood in our work allows a simplification of the selection event, without
which the conditional methods are computationally less feasible in high dimensions. The
proposed reparameterization map furnishes tractable updates for the posterior at each draw
of a sampler on very modest computing costs.
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1.1 Radiogenomic case study: LGG
A radiogenomic investigation broadly refers to a task of utilizing routine records from mag-
netic resonance imaging (MRI) as mineable knowledge to assess their correlations with ge-
nomic markers. Then, these associations are used to establish biological links with patient
outcomes during downstream modeling (Rutman and Kuo, 2009; Mazurowski, 2015; Gevaert
et al., 2017). Well acknowledged in several leading-edge studies, genomic instability and mu-
tations are a hallmark of cancer. Nonetheless direct relations of genes with clinical endpoints
often prove to be quite limiting in terms of prognostic abilities, with the resulting models
typically failing to explain much variability in critical outcomes. These limitations have
prompted integrative radiogenomic investigations (Guo et al., 2015; Bakas et al., 2017) to
tackle the lack of efficacy of direct modeling in the context of cancer.
Our methods derive motivation from a radiogenomic analysis for diffuse low-grade gliomas
(LGG). LGG are primary brain tumors with a mean survival time of seven years. Some
of these tumors progress very quickly into high-grade tumors. Extracting samples of LGG
patients from the public repositories– the TCGA (The Cancer Genome Atlas) and TCIA (The
Cancer Imaging Archive)– we use our proposed Bayesian machinery to discover biologically
relevant gene pathways associated with patient outcomes. The genomic markers in our
analysis are measured via pathway scores (Vasaikar et al., 2017), which are quantitative
representations of the activity of sets of genes. Playing the role of intermediary phenotypes,
radiological imaging characteristics in our study are captured by principal component scores
(hereafter referred to as radiomic phenotypes) that represent most of the variability in voxel-
level tumor characteristics. Reusing the data samples allocated for model selection, we
provide uncertainties associated with these discoveries.
1.2 Post-selective inference for integrative models
In adopting an integrative approach to the radiogenomic problem, data-driven modeling is
necessitated by the highly dimensionality across the two domains of information. The number
of matched samples across genomics and radiomics ranges barely in double digits. The gene
pathways and imaging phenotypes however are typically on the order of thousands and
hundreds respectively. To be specific, we analyze a sample size of only 60 matched patients
for LGG across genomics and radiomics in our case study. Combining signals unearthed
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by powerful penalized variable selection schemes (Tibshirani, 1996; Zou and Hastie, 2005),
with domain specific knowledge is therefore critical for formulating sharp and reproducible
models, embedded in a high dimensional covariate space. Our Bayesian methods use these
adaptive radiogenomic models to furnish effect-size sizes for gene pathways, which explain
heterogeneity in different aspects of tumor morphology as well as the outcome of interest.
The rest of the article is organized as follows. Section 2 outlines the modeling framework
and discusses a selection-corrected posterior for a data-driven model. Section 3 develops
the technical core of the paper by deriving tractable expressions for a simplified posterior
after accounting precisely for the mining pipeline. Explicit analytic formulae in this section
hinge essentially on a conditional likelihood and a relevant reparameterization map. Section
4 explores in depth the potential of our proposal for data that utilizes genomic and radiomic
measurements in integrative Bayesian models. Section 5 concludes with integrative data
driven inference for biologically critical gene pathways, taking therefore a step towards a
molecular understanding of LGG.
2 Modeling framework
Introducing notations, we let n denote the number of matched samples and let p and L repre-
sent the number of explanatory and intermediary variables respectively. In the radiogenomic
case study of interest, the explanatory and intermediary variables are gene pathway scores
and imaging (radiomics) scores measured for matched samples across the two modalities of
information. Further, we denote the outcome variable as Y ∈ Rn, the predictor matrix for
the n samples as G ∈ Rn×p and the intermediate phenotype measurements for the n matched
samples as I ∈ Rn×L where Il represents the l-th column of I. Finally, let GF be a matrix
that includes a subset of the columns of G that are present in the set F ⊂ {1, 2, · · · , p}.
2.1 Mining pipeline
Before we can describe the modeling framework, we discuss the regularized variable selection
pipeline involved in mining models adaptive to the embedded sparsity. Divided into two
stages, the first step in the pipeline uses a regression framework based on intermediary
phenotypic variables. This stage leads to a promising candidate set of explanatory variables,
which in turn facilitates a powerful downstream modeling of the underlying response.
In the second step, we utilize a randomized regression (Tian and Taylor, 2018; Panigrahi
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et al., 2019) to further select variables from the candidate set in the first stage that are as-
sociated with the outcome of interest. Described below, a randomized strategy at this step
perturbs the canonical algorithm with a randomization variable. Demonstrated through in-
depth simulations in the paper, we will show that randomization enables a better tradeoff in
the use of information within the available samples for model selection and follow-up infer-
ence. We will show that conditional inference after randomized strategies result in sharper
models with inferential estimates dominating those produced by the commonly deployed
sample-splitting in terms of power.
1. A start point in this pipeline is a set of promising explanatory variables associated with
the intermediary phenotypes. Adopting a multiple regression framework in this step, we
solve L `1 penalized queries (Tibshirani, 1996) where the outcome in the l-th query is Il:
(α̂F̂l , 0) = arg minα
‖Il −Gα‖22 + λl‖α‖1 for l = 1, 2, · · · , L; (1)
λl is the tuning parameter for the `1 penalty.
Letting F¯ = ∪Ll=1F̂l with F̂l representing gene pathways selected by (1) when regressed
against the l-th imaging score, F¯ is a candidate set of favorable explanatory variables for
the next mining step. In addition to the selected pathways in our selection pipeline, we
record the proportion of times a pathway is selected across all the regularized queries and
denote this proportion by pj;F¯ for a gene pathway j in the set F¯ .
2. Focusing next on the associations between GF¯ and Y , we implement a randomized version
of Lasso:
(β̂ LASSO
Ê
, 0) = arg min
β
‖Y −GF¯β‖22 + ‖Λβ‖1 +  · ‖β‖2/2−RTβ, (2)
where Ê is the set of Lasso estimates not shrunk to zero. In the above optimization, the
variable R is distributed as a centered Gaussian variable, with isotropic variation η2 · I,
independent of (Y, Il, 1 ≤ l ≤ L) and is termed as a randomization variable (Tian and
Taylor, 2018; Panigrahi et al., 2018).
Noticeably, the optimization objective (2) differs from a canonical version of Lasso through
an additional term, which is linear in the randomization instance R and an `2 penalty
with a small positive coefficient  > 0. We refer readers to Tian et al. (2016) for an
introduction into such a randomized formulation. In general, the `1 penalty matrix in
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(2), Λ = diag(λ1, · · · , λF¯ ), can be chosen to reflect the importance of each predictor
variable in the candidate set F¯ . Setting the penalty weights to be inversely proportional
to pj;F¯ from the preceding multiple-regression stage is one such way to incorporate the
relative importance of the explanatory variables during downstream modeling.
2.2 Integrative Bayesian models post selection
Next we describe a data driven family of models after observing the selection outcomes
Ê(Y,R;GF¯ ) = E where F¯ = ∪Ll=1F̂l(Il, G) and F̂l(Il, G) = Fl (3)
from the variable selection algorithms in Section 2.1. To define a class of data driven models,
we denote as
E : (E, {Fl, 1 ≤ l ≤ L},D)→ E¯, (4)
a function that maps the interaction between the data dependent selection outcomes {Fl, 1 ≤
l ≤ L} and E from the regressions in (1) and (2) and domain specific knowledge D, which
does not depend on data at all, to a set E¯ ⊂ {1, 2, · · · , p}. The model linking the primary
outcome to the explanatory measurements is parameterized by the data driven output E¯ in
(4). Explicit in the definition of the mapping E , the only underlying assumption we make
about our model is that it depends on the variables (Y,G, I,R) exclusively through the
selected variable sets, {Fl, 1 ≤ l ≤ L} and E.
With the adaptive parameters determined by the set E¯ in (4), we assume a linear depen-
dence model between Y and GE¯ such that each sample i is identically and independently
distributed as
Yi = Gi,E¯βE¯ + i, where i ∼ N(0, σ2), (5)
under a fixed predictor matrix framework; Gi,E¯ here denotes the i-th row of the matrix
GE¯. For modeling the associations between the intermediary and explanatory variables, we
assume for now
Ii,l = Gi;FlαFl + Ψi,l, 1 ≤ l ≤ L, where (Ψi,1, · · · ,Ψi,L) i.i.d.∼ N(0,ΣI), (6)
and Ψi = (Ψi,1, · · · ,Ψi,L) is independent of i in the primary model of interest (5).
Completing the model specification in a Bayesian framework, we impose a rich family of
Gaussian priors pi(·) on the adaptive parameters βE¯, our main inferential target in (5). We
define the following prior
βE¯ | (η21, η22, · · · , η2|E¯|)T ∼ N(0, σ2diag(η21, η22, · · · , η2|E¯|)); η2j ∼ N(0, λ2), j ∈ E¯. (7)
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Marginalizing over
(
η21 η
2
2 .. η
2
|E¯|
)T
yields a prior for βE¯ (Park and Casella, 2008) that is
proportional to
|E¯|∏
j=1
exp(−(σλ)−1 · |βj;E¯| ).
Noteworthy from the perspective of a flexible modeling framework, we emphasize for our
readers the following aspects of the assumptions.
Remark 1. The interaction map E is allowed to be a black box as long as it depends on the
data only through the outcomes of the regularized model selection algorithms. Importantly,
this implies that our inferential machinery does not need an explicit specification of this
interaction function E during inference, requiring only the knowledge of the final output E¯.
Therefore, our data can be flexibly modeled via a complicated interplay between the data
dependent algorithms and existing domain knowledge. This is consistent with most realistic
scenarios where the interplay might be hard to specify.
Remark 2. The validity of our inferential approach is not tied to (6), the selected linear
model between the explanatory and intermediary variables. To this end, our methods rely
only upon the independence between i and Ψi for each independent data sample. We point
out to Proposition 1 in the next section. For the sake of simple exposition of our methods,
we assume this simplified form for the intermediary models.
2.3 A selection-corrected posterior
To explicitly account for the data interactive nature of modeling, our methods use a selection-
corrected posterior. A key component of this posterior is a conditional likelihood (Bi et al.,
2017; Panigrahi et al., 2016). Truncated to all data realizations that result in a data driven
model (5), the conditional likelihood discards the information utilized during model selection
(Lee et al., 2013) and is stated in Proposition 1 as a function of the adaptive parameters βE¯
in the primary outcome model.
Proposition 1. Define β̂E¯ = (G
T
E¯
GE¯)
−1GE¯Y to be the least squares estimate in the primary
submodel E¯. Let ΣE¯ be the covariance matrix of β̂E¯. Then, under the modeling assumptions
(5) and (6), a likelihood involving β¯E conditional upon the data dependent selections
F̂l(Il, G) = Fl for 1 ≤ l ≤ L, Ê(Y,R;GF¯ ) = E,
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is proportional to
(2pi)−|E¯|/2 · det(ΣE¯)−1/2 · exp(−(β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2)
×
{
P[Ê(Y,R;GF¯ ) = E | βE¯]
}−1
.
In Proposition 1, P[Ê(Y,R;GF¯ ) = E | βE¯] is the probability of selecting the variable
set E after solving (2), expressed as a function of βE¯. Appending the prior in (7) to this
likelihood results in a selection-corrected posterior with a generally intractable selection
probability. Theoretical concentration properties of the posterior derived from Proposition 1
around the generative parameters are investigated previously in Panigrahi et al. (2016), where
a moderate deviations bound is used to approximate the otherwise unavailable selection
probability in closed forms.
Here we emphasize that the application of any standard sampling scheme that targets
the corrected posterior involves computing
P[Ê(Y,R;GF¯ ) = E | β(d)E¯ ]
at the parameters β
(d)
E¯
of each new draw (d) from the sampler. Warranting computationally
efficient algorithms to infer using the selection-corrected posterior, our methods propose the
use of an appropriate conditional likelihood with a prudent choice of conditioning event.
This is followed by a careful reparameterization map to draw samples from a transformed
parameter space. Deferring the details of these two integral steps to Section 3, our goal
hereafter is to obtain easy updates for this posterior under standard sampling procedures.
2.4 A first example: using radiogenomic predictors
Below, we summarize the potential of our methods through a motivating example using the
genomic and imaging measurements from the radiogenomic analysis. Generating a sparse
model with both weak and strong signals of varying amplitudes and random signs, we draw
in each round of simulation an outcome from the primary model (5). The signal vector β is
generated from a mixture of centered Laplace distributions, the true underlying prior. That
is, each coordinate is drawn as follows
βj ∼ Πj(·) := pi · Laplace(0, 0.10) + (1− pi) · Laplace(0, s) for 1 ≤ j ≤ r; (8)
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r = |F¯ |. Varying the scale of the Laplace distribution, s and the mixing proportion, pi leads
to different signal regimes. Consistent with the dimensions of the radiogenomic application
at hand, the number of samples in the simulations equals 60.
Selecting a data driven model using the mining pipeline in Section 2.1 and employing the
proposed Bayesian machinery with a selection-corrected posterior at the core, we bring to the
fore the advantages of adopting a rather intricate conditional approach. Noteworthy in the
results is a tradeoff in the quality of model selection and inferential power, which is imminent
when data must be used for model selection as well as inference. We set the randomization
variation η2 in (2) to be equal to the noise level in the outcome (estimated from data).
We showcase comparisons of our approach with sample-splitting, a state-of-art strategy that
overcomes selection bias by using one portion of the data for model formulation and reserving
the remaining portion for follow-up estimation. Setting pi = 0.95 in the true generative
scheme (8) and varying the variance of the Laplace distribution between {0.20, 1, 2, 4}, we
consider 4 signal regimes– numbered 1-4 on the x-axis of Figures 1 and 2.
1 2 3 4
signal regimes
0.0
0.2
0.4
0.6
0.8
1.0
1 2 3 4
signal regimes
0.0
0.2
0.4
0.6
0.8
1.0
1 2 3 4
signal regimes
0.0
0.2
0.4
0.6
0.8
1.0
coverage: naive vs Proposed
Figure 1: Invalidity of naive inference (in orange): the x-axis represents different signal
regimes and the y-axis plots empirical coverage of 90%-intervals across the regimes. Left
panel shows the distribution of naive estimates that ignore adaptive nature of model; cen-
tral panel compares the averaged coverages across the regimes; right panel plots empirical
distribution of the proposed intervals. The dotted line at 0.90 is the nominal coverage.
Figure 1 anchors the motivation behind using a selection-corrected posterior. The distri-
bution of the empirical coverages of naive interval estimates that do not account for the data
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1 2 3 4
signal regimes
0
5
10
15
20
25
length of intervals
Proposed
split (50%)
split (60%)
split (70%)
split (80%)
split (90%)
1-3 4-6 >6
number of signals
0.0
0.2
0.4
0.6
0.8
1.0
power of adaptive model
Figure 2: Tradeoff in model selection and inferential power: left panel highlights the quality
of our adaptive model measured via the screening power of true signals; right panel shows
the distribution of averaged lengths of interval estimates, a metric associated with inferential
power.
driven nature of models have averaged coverage falling way short of the benchmark target of
90% on the one hand. On the other hand, the credible intervals furnished by our methods
support the validity and necessity of the inferential proposal in the article.
Figure 2 exemplifies a significantly better reconciliation between the quality of model
selection and inferential power in comparisons with splitting, when different proportions
of data employed for selection and inference. Specifically, the performance of the rather
unconventional randomized query (2) in terms of model selection is evaluated using the
number of true signals screened under different sparse scenarios. The follow up inferential
power is measured as the averaged lengths of interval estimates. We remark here that our
radiogenomic case study is in fact confronted with relatively very few samples in comparison
to the dimensions of covariate spaces. In this context, an effective balance of information
in the available data for these two tasks severely impacts the number of discoveries and the
power of effect-size estimation associated with them.
Evident from the left panel of Figure 2, splitting where 90% of the data is assigned for
selecting signals is the best performer amongst all the split-based methods towards selecting
a powerful model. However, this power is clearly dominated by the randomized scheme we
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adopt for modeling. While assessing inferential power, our methods adjusting appropriately
for the data driven nature of the model provide interval estimates that are less than half
the length of the 90% split-based intervals. An important take away for our readers is
therefore the attractive alternative that our methods offer in comparison to splitting at
sample proportions across the range. This shows that we allow a distinctly unique yet more
efficient tradeoff in the use of information for modeling and follow-up effect size estimation.
3 Posterior inference for data driven models
To proceed with inference, we describe the technical machinery to obtain analytic expressions
for the selection-corrected posterior and the corresponding gradient. These are essential
ingredients that a large family of Markov chain Monte Carlo sampling schemes warrant
in order to furnish estimates of uncertainty. The main results in this section 1) provide a
simplified conditional likelihood for computational tractability; see Theorem 1, and 2) derive
a selection-corrected posterior with transformed parameters for easy sampler-based updates;
see Theorems 2 and 3.
3.1 A simplified conditional likelihood
Before deriving the proposed conditional likelihood, we describe in Proposition 2 the intricate
selection event that the likelihood is conditioned upon in Proposition 1. To describe our
results with concise notations, with a slight abuse we denote as GE the submatrix of GF¯ with
the selected columns indexed by E. Letting the coordinates not selected by the randomized
LASSO (2) be denoted by Ec = F¯ \ E, we now represent the stationary equation at the
solution as RE
REc
+
GTEY
GTEcY
−
ΛEsE
ΛEcz
 =
GTEGE + I
GTEcGE
 β̂ LASSOE ; (9)
where β̂ LASSOE denotes the LASSO solution for the E active coordinates (not shrunk to 0),
sE is a vector of signs of these active LASSO solutions and z corresponds to the inactive part
of the subgradient from the `1 penalty. In the above equation, the active solution β̂
LASSO
E
and the inactive coordinates of the subgradient z in (9) further satisfy the constraints
sign(β̂ LASSOE ) = sE ; ‖z‖∞ < 1. (10)
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The selection of an active set E is associated with the event {(y, r) : Ê(y, r) = E},
described in terms of realizations of the outcome variable y and the randomization r. Based
on these notations, Lemma 2 characterizes this selection event as a union of polyhedral
regions, determined by
{
UsE , VsE ,WsE , tsE : sE = {−1, 1}|E|
}
.
Proposition 2. After solving (2), the selection event {(y, r) : Ê(y, r) = E} under a fixed
predictor matrix framework is equivalent to⋃
sE={−1,1}|E|
{
UsE β̂E¯ + VsE(rE, rEc)
T +WsE(β̂
⊥
E , β̂
⊥
Ec)
T > tsE
}
,
where β̂⊥ = GT
F¯
y −GT
F¯
GE¯β̂E¯, β̂E¯ = (G
T
E¯
GE¯)
−1GT
E¯
y and
UsE =

diag(sE)(G
T
EGE + I)
−1GTEGE¯
GTEcGE¯ −GTEcGE(GTEGE + I)−1GTEGE¯
−GTEcGE¯ +GTEcGE(GTEGE + I)−1GTEGE¯
 ,
VsE =

diag(sE)(G
T
EGE + I)
−1 0
−GTEcGE(GTEGE + I)−1 I
GTEcGE(G
T
EGE + I)
−1 −I
 ,WsE =

diag(sE)(G
T
EGE + I)
−1 0
−GTEcGE(GTEGE + I)−1 I
GTEcGE(G
T
EGE + I)
−1 −I

tsE = (diag(sE)(G
T
EGE + I)
−1ΛEsE,−λEc −GTEcGE(GTEGE + I)−1ΛEsE,
− λEc +GTEcGE(GTEGE + I)−1ΛEsE)T .
Conditioning on {(y, r) : Ê(y, r) = E} thus results in very complicated constraints on
the data and randomization, evident from Proposition 2. Pointed out in Proposition 1, a
complex event makes the computation of the probability of selection harder. We note how-
ever that conditioning upon some additional information, recognized in Theorem 1 simplifies
considerably these selection constraints to simple sign restrictions on variables. The prob-
ability of selection now takes the form of an integral over an orthrant determined only by
sign constraints. This is formalized in our next Theorem.
Theorem 1. Conditional upon {Ê = E, sign(β̂LASSOE ) = sE, z = zobs, β̂⊥ = βˆ⊥,obs}, the
likelihood of β̂E¯ under the modeling assumptions in (5) and (6) is proportional to( ∫
sign(w)=sE
(2pi)−|E¯|/2 · det(ΣE¯)−1/2 · exp(−(b− βE¯)TΣ−1E¯ (b− βE¯)/2)
(2pi)−|E|/2 · det(QTQ/η2)1/2 exp(−(w − p(b))TQTQ(w − p(b))/2η2)dwdb
)−1
× (2pi)−|E¯|/2 · det(ΣE¯)−1/2 exp
(
−(β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2
)
;
(11)
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where Q =
GTEGE + I
GTEcGE
, p(b) = (QTQ)−1QT (GT
F¯
GE¯b+ βˆ
⊥,obs − (ΛEsE,ΛEczobs)T
)
.
We observe that conditioning upon additional information such as the signs of active
variables is pursued in prior conditional methods (Tibshirani et al., 2016; Lee et al., 2013) to
obtain a convex selection region. The selection-corrected posterior we finally obtain appends
the conditional likelihood in Theorem 1 with the prior in (7).
The probability of selection involved in the normalizer of the conditional likelihood (11)
nonetheless lacks a readily available closed form. Based upon a Laplace approximation
to the normalizer of the conditional likelihood, recent work (Panigrahi and Taylor, 2019,
see Proposition 3.1) provides an approximate expression for the logarithm of the otherwise
intractable likelihood. Deferring details of this approximation to the Appendix B, (12) states
the approximate version of the (log-) selection-corrected posterior
log pi(βE¯)− (β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2
+inf
b,w
{
(b− βE¯)TΣ−1E¯ (b− βE¯)/2 + (w − p(b))TQTQ(w − p(b))/2η2 + CsE(w)
}
,
(12)
where
CsE(w) =
|E|∑
j=1
log(1 + (QTQ)
1/2
j,j · (ηsE;jwj)−1) =
|E|∑
j=1
Bj(wj),
(QTQ)
1/2
j,j is the j-th diagonal entry of (Q
TQ)1/2; sE;j is the j-th entry of the sign vector sE.
3.2 Posterior via a transformation of parameters
We obtain analytic expressions for the approximate (log-) selection-corrected posterior (12)
and the corresponding gradient via a carefully constructed reparameterization map. This
gives us samples on a transformed space when standard sampling techniques are applied for
uncertainty estimation. From now on, we denote
p(b) = Pb+ o; P = (QTQ)−1QTGTF¯GE¯, and
o = (QTQ)−1QT
(
βˆ⊥,obs − (ΛEsE,ΛEczobs)T
)
.
Define a reparameterization map
ζE¯ = Ψ
−1(βE¯)
14
where Ψ : ζE¯ → βE¯ is given by
βE¯ = Ψ(ζE¯) =
(
I + η−2ΣE¯P
TQTQP
)
ζE¯ + η
−2ΣE¯P
TQTQ(o− w∗(ζE¯)) (13)
and
w∗(ζE¯) = argmin
w
(w − p(ζE¯))TQTQ(w − p(ζE¯))/2η2 + CsE(w).
We denote the transformed posterior in Theorem 2 by log pi(ζE¯|β̂E¯).
Theorem 2. Using a change of variables from βE¯ → ζE¯ based on the reparameterization
defined in (13), the logarithm of the selection-corrected posterior for the transformed param-
eters ζE¯ equals
log pi(Ψ(ζE¯)) + log |det(J (ζE¯))|+ β̂TE¯Σ−1E¯ Ψ(ζE¯)− ζTE¯Σ−1E¯ Ψ(ζE¯)
+ ζTE¯Σ
−1
E¯
ζE¯/2 + (w
∗(ζE¯)− PζE¯ − o)TQTQ(w∗(ζE¯)− PζE¯ − o)/2η2 + CsE(w∗(ζE¯)),
where J (ζE¯) is given by(
I + η−2ΣE¯P
TQTQP
)
− η−4ΣE¯P TQTQ
(
η−2QTQ+∇2CsE(w∗(ζE¯))
)−1
QTQP.
(14)
Define C˜sE(w
∗(ζE¯)) to be a diagonal matrix such that the l-th diagonal entry equals
∇3Bl(w∗l (ζE¯)) and let diag(V ) denote a diagonal matrix with the vector V along the diag-
onal. Finally, define N = η−2QTQ +∇2CsE(w∗(ζE¯)). Then, our next theorem provides an
expression for the gradient of the posterior on the transformed space.
Theorem 3. Under the reparameterization map βE¯ → ζE¯ in (13), the gradient of the (log-)
selection-corrected posterior pi(ζE¯|β̂E¯) is given by
(J (ζE¯))T
(
∇ log pi(Ψ(ζE¯)) + Σ−1E¯ β̂E¯ − Σ−1E¯ ζE¯
)
+
(
M1(ζE¯) · · · M|E¯|(ζE¯)
)T
where J (ζE¯) is given by (14) in Theorem 2, the j-th column of η−2N−1QTQP is denoted by
Jj and Mj(ζE¯) equals
Trace
(
η−4J −1(ζE¯)ΣE¯P TQTQN−1
(
C˜sE(w
∗(ζE¯)) · diag(Jj)
)
N−1QTQP
)
for j = 1, 2, · · · , |E|.
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Finally we note that with a sample ζ
(d)
E¯
from the selection-corrected posterior in Theorem
2, we can reconstruct the corresponding draw for our target parameter β
(d)
E¯
using the map
defined in (13). We note that no additional cost is incurred in this step, as it involves the
optimizer w∗(ζ(d)
E¯
). This is the step which involves core computing cost in obtaining the
expressions of the log-posterior and the gradient.
Based on the expressions for the (log-) posterior and the gradient in Theorems 2 and 3, a
sampler will rely upon solving the optimizer w∗(ζ(d)
E¯
) at each new draw (d) of the transformed
parameters ζ
(d)
E¯
. Important from the perspective of sampling efficiency, the optimization
objective solved for every update of the transformed posterior is only |E| dimensional, the
size of the selected set of variables. We highlight that the effective dimension of our problem
reduces to the selected size at the end of the mining pipeline, way smaller than the high
dimensional start set of p potential explanatory variables. Further, the optimization solved
for posterior sampling coincides exactly with a frequentist problem computing the maximum-
likelihood based estimate from a selection-corrected likelihood (Panigrahi and Taylor, 2019).
4 Simulation analysis
In this section, we demonstrate the reconciliation between the data driven nature of models
and the validity of inferential estimates achieved through our methods. The design of ex-
periment in the empirical analysis is consistent with the simulations in Section 2 in terms of
the signal regimes. Particularly, we present results that illustrate how inferential metrics in
the motivating example generalize to varied parameters.
4.1 Simulation design
To generate our data, we vary the ratio between number of samples, n and the number of
regressors, r before screening out the set E to determine the primary model (5) in conjunction
with domain knowledge. We investigate specifically the sample sizes n = 180, 360, 720 to
match the dimension ratio r/n = 2, 1, 0.5 respectively. In the real data analysis and the
motivating example in Section 2, note that r/n ≈ 5, n = 60, r = 357 and the predictor
matrix we use is based on the real values of genomic and radiomic measurements. Details
on the acquisition of this data is included in the next section.
To generate predictor measurements for sample sizes larger than 60, we append synthetic
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design values to the real design matrix in order to achieve the studied regression dimensions.
Specifically, we draw xi ∈ Rr, 1 ≤ i ≤ n1 such that xi ∼ N(0,Σ(ρ)), for i = 1, 2, · · · , n1 and
n1 is chosen so that r/(n1 + n) = 2, 1, 0.5 in the three case studies of interest; Σ(ρ) is an
autocorrelation covariance matrix such that the Σi,j = ρ
|i−j| and ρ = 0.70.
The signal vector in the simulations is generated from a mixture of Laplace distributions
in (8), with sparsity levels controlled by the mixing proportion. Our strategy to reflect a
realistic data generation process through simulations is aligned along the following principles.
First, we note that the variability in the outcome variable is explained by multiple markers,
consistent with our expectation of a polygenic response variable. Second, the generative
model incorporates a mix of weak and strong signals with varying amplitudes and random
signs. This enables us to investigate the ability of our inferential method to adapt to the
strength of the signals present in the data and to reconstruct efficiently the corresponding
effect sizes. Finally, admitting different regression dimensions, our simulations showcase (i)
the necessity of adopting our methods even in moderate dimensions where a severe impact
of selection bias is seen and (ii) our methods support a greater number discoveries, with
clearly shorter and hence more powerful inferential estimates than the benchmark approach
of splitting deployed widely by practitioners.
4.2 Inferential results: a discussion
The inferential metric we focus on in our analysis is a tradeoff between model selection and
inference, inevitable in data driven inference. This tradeoff is very crucial in evaluating the
quality of selection as well as the power associated with follow-up uncertainty quantification,
the two critical metrics associated with an inferential pipeline. A first metric we showcase
in our example is the inferential validity of interval estimates based upon a sample from
the selection-corrected posterior. Utilizing the expressions of the reparameterized version in
Theorems 2 and 3, we construct intervals for βE¯ in the model specified by (5) and (7), where
E¯ = E is the final output of the regularized variable selection algorithms.
The validity of inference is depicted in terms of the averaged coverage of the 90%-credible
intervals, see Figure 3. Importantly, this figure emphasizes the strong need to correct for
selection bias while inferring in data driven models. We remark here that the coverage of
the naive intervals worsens in comparison to the case study analyzed under Section 2. This
difference in the behavior of the naive intervals can be attributed to the synthetic predictor
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Figure 3: The x-axis represents different signal regimes and the y-axis plots empirical cover-
age of 90%-intervals across the regimes with the dotted line at 0.90 as the target coverage.
The panels depict the averaged coverages of naive and Proposed intervals across the regres-
sion dimensions r/n = 2, 1, 0.5, highlighting the severely flawed nature of inferential decisions
when the data driven nature of models is ignored in moderate dimensional regimes.
values we append to the real genomic and radiomic observations in the simulations in order
to vary the size of regression.
In Figure 4, we highlight 1) the power of the data driven model in the panels (a), (b),
(c) in terms of the number of signals screened by the randomized strategy (2) and split-
based schemes and 2) inferential power in the panels (d), (e), (f) measured as the averaged
lengths of the interval estimates produced by the Bayesian machinery in the paper when
compared to state-of-art splitting. Consistent with the findings in the motivating example,
the proposed methods dominate all the split-based methods when assessed for the quality
of the selected model; the percentage in the legend indicates the proportion of samples used
for model selection.
In balancing the allocation of samples towards the two tasks of model selection and infer-
ence, splitting based on 90% of the samples for selection produces the best model amongst
the split-based strategies. Yet, this split-based method falls short of the randomized se-
lection in terms of the quality of the primary model of interest. Comparing the averaged
lengths of the interval estimates in the four signal regimes and under the different regression
dimensions, we note that the data driven Bayesian inferential methods yield intervals that
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Figure 4: Evaluation of selected model in Panels (a), (b), (c) and inferential power in Panels
(d), (e), (f)– a balance in the two inferential metrics.
are shorter by two-three times than split (90%). On the other hand, choosing a split-based
approach with 50% of the samples devoted for model selection results in a relatively worse
data driven model to start with. Therefore such a method leads to lesser discoveries which
are left out in the selection stage. The results in Figure 4 summarize the clear advantages
that the intricate conditional techniques enjoy over the common practice of splitting the
data into two parts. The correction after randomizing and via conditioning take into ac-
count precisely the selection of the data driven model and allow an optimal reuse of data
samples during inference.
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5 Radiogenomic analysis for LGG
We turn our attention to a radiogenomic analysis where the genomic and radiomic features
capture complementary characteristics of the underlying tumor. These measurements are
collectively harnessed in integrative models to assess associations with relevant clinical end-
points such as disease progression, survival time etc. for the patients. Before a demonstration
of our methods, we provide the details related to data acquisition and pre-processing of both
the imaging and genomic modalities with specifics largely deferred to Appendix C. We follow
this up with the results from the mining pipeline and the implementation of the inferential
machinery in Section 5.2. Finally, in Section 5.3, we discuss the biological insights into our
radiogenomic findings and the relevance of the resulting effect size estimates in the context
of recent scientific literature.
5.1 Pathway scores and radiomic phenotypes
We obtain the genomic data from LinkedOmics (Vasaikar et al., 2017), a publicly available
portal that includes multi-omics data from multiple cancer types in TCGA. The genomic
data we acquire are normalized gene-level RNA sequencing data from the Illumina HiSeq
system (high-throughput sequencing) with expression values in the log2 scale. Focusing on
subjects with LGG, the gene expression data includes 516 samples and 20086 genes, which
is narrowed down further to the matched samples with imaging in an integrative study.
A set of genes broadly constitutes a gene pathway. In our case, we derive the path-
way membership of genes from the Molecular Signature Database (Liberzon et al., 2011), a
publicly available resource containing annotated gene-sets divided into multiple collections
(groups of pathways). Particularly, we consider four collections namely Hallmark Pathways
(50 pathways), KEGG Canonical Pathways (KEGG - 186 pathways), Cancer Gene Neigh-
borhoods and Cancer Modules (C4 - 858 pathways), and Oncogenic Signatures (C6 - 189
pathways). In Appendix C.1, we discuss the construction of pathway scores for these genomic
measurements.
For the imaging records, we obtain the pre-operative multi-institutional MRI scans of
TCGA LGG collection available in TCIA (Clark et al., 2013). For our analysis, we consider
four types of MRI sequences which include (i) native (T1), (ii) post-contrast T1-weighted
(T1Gd), (iii) T2-weighted (T2), and (iv) T2 fluid attenuated inversion recovery (FLAIR)
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volumes. Each of these sequences display different types of tissues with varying contrasts
based on the tissue characteristics. From the whole brain MRI scans, the tumor regions can
be identified using an automated segmentation method called GLISTRboost (Bakas et al.,
2015, 2017). These segmentation labels additionally identify each voxel as one of the three
tumor sub-regions namely, necrotic and non-enhancing tumor core (NC), the peritumoral
edema (ED) and the enhancing tumor (ET). In Figure 5, we show an axial slice from the
MRI scan of a LGG subject corresponding to all four imaging sequences as well as the
segmented tumor sub-regions.
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Figure 5: An axial slice of a brain MRI from four modalities: T1, T1Gd, T2 and FLAIR for
a LGG subject. The segmented tumor region is shown with an (red) overlaid boundary. Seg-
mentation mask indicates the necrotic and non-enhancing tumor core (NC), the peritumoral
edema (ED) and the enhancing tumor (ET) regions.
The voxel intensity values so obtained are sensitive to the configuration of the MRI ma-
chine and are difficult to interpret. These values are neither comparable across different
subjects, nor between study visits for the same subject. We address this issue by imple-
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menting a biologically motivated normalization technique called white-stripe normalization
(Shinohara et al., 2014). Finally, we work with the intensity values corresponding to each of
the 12 group of voxels (4 MRI sequences and 3 tumor sub-regions) separately. For each of
the 12 groups of intensity values, we construct kernel density estimates for all the 61 sub-
jects. These densities give rise to the principal component scores for each of the 12 groups
separately, whose details are included in Appendix C.3.
5.2 Mining pipeline with radiogenomic characteristics
The first stage of the mining pipeline begins by identifying a set of promising pathways
associated with the radiomic-based intermediary phenotypes. Our start point is solving (1)
with the 143 principal component scores across the 12 groups of tumor voxels as responses,
regressed against 1289 pathways from the four pathway collections (Hallmark, KEGG, C4,
and C6). The output of this step is a set of 369 gene pathways, each of which is associated
with one or more of the radiomic phenotypes. These are promising candidates for the second
stage of our mining pipeline where associations with the outcome of interest are evaluated.
Of these 369 pathways selected, the multiplicity of each pathway defined as the number of
LASSO queries which selects this potential predictor ranges between 1 to 9.
In the second step, (2) deploys a randomized version of LASSO to partition the infor-
mation within the data at hand towards selecting a model, followed by reliably calibrating
strengths of these selected associations. The penalty weights in the LASSO are set to be in-
versely proportional to the multiplicity of a pathway, in order to reflect an importance weight
for that feature in terms of its association with the imaging scores. We select 15 pathways
from this second stage regression, the ones explaining the variability in the primary response
and the intermediary imaging scores. Setting E¯ = E in (5) and using the prior in (7), and
ultimately, relying upon the analytic formula for the corrected posterior in (2), we obtain
samples from the posterior adjusted precisely for selection bias. Inference for the data driven
parameters βE now enables effect size estimates corresponding to the 15 reported pathways.
In Figure 6 we showcase the bounds for 50%, 80% and 95% credible intervals based on the
MCMC samples for the 15 reported pathways.
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Figure 6: Bounds of the credible intervals for the gene pathways associated with the overall
survival and with the radiomic characteristics.
5.3 Biological Interpretations
In this section, we focus on some of our findings, providing their biological interpretations
and discussing them in the context of clinical knowledge in this domain.
1. We see that the gene pathway, Vascular Smooth Muscle Contraction, from the KEGG
collection has significant association with overall survival. Vascular smooth muscle cell
(VSMC) is a highly specialized cell whose principal function is contraction. These cells
shorten on contraction, consequently decreasing the diameter of a blood vessel to regulate
the blood flow and pressure (Liberzon et al., 2011). Moreover, in a clinically relevant
mouse model of glioma, it was found that the glioma cells disrupt the VSMCs as they
populate the perivascular space of preexisting vessels, causing a focal breach in the blood
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brain barrier (Watkins et al., 2014). It has been demonstrated that endothelial specific
growth factor such as, vascular endothelial growth factor (VEGF), can interact with non-
endothelial cells and play a role in modulating the response of VSMCs (Ishida et al., 2001).
VEGF expression levels were associated with the presence of ringlike tumor contrast
enhancement, which present phenotypically as variable contrast on T1Gd MRI scan and
were jointly associated with progression-free survival in glioblastoma (Wang et al., 2016).
2. The gene pathway denoted as MORF PDCD1 which includes the genes in the neigh-
borhood of the gene PDCD1, is seen to have a significant association with the overall
survival. Recent work (Ro¨ver et al., 2018) indicates that PDCD1 promoter methylation
is a prognostic factor in LGG with Isocitrate Dehydrogenase (IDH) mutations. It is known
that high expression of PDCD1 on the immune cells infiltrating the LGG is a marker for
immune evasion and associated with survival.
3. Another significant association we notice in our analysis corresponds to the gene pathway
GNF2 MYL2. This is a group of genes in the neighborhood of MYL2 (myosin light chain
II). Previous studies (Beadle et al., 2008) show that myosin II plays a significant role in
glioma invasion in vivo, where it regulates the deformation of the nucleus as well as the
membrane of glioma cells. This has been further validated through mathematical mod-
eling in recent literature (Lee et al., 2017). Notably the extent of immune/inflammatory
activity is reflected through the edema region on MRI scan (Kleijn et al., 2011).
Some of the other pathways associated with the overall survival include metabolic path-
ways from KEGG such as (a) pentose and glucuronate interconversions, (b) glyoxylate and
dicarboxylate metabolism, and (c) butanoate metabolism. In light of the significant role
that metabolic reprogramming plays in glioma pathogenesis (Strickland and Stoll, 2017), it
is encouraging to see that a number of metabolic pathways are identified to be significantly
associated with patient prognosis. From the pathways for cancer gene neighborhoods we
see significant associations with the gene pathways such as neighborhoods of (a) MYST2, a
histone acetyltransferase that plays crucial functions in transcription, DNA replication and
repair, and (b) CDKN1C, which is known to regulate several of the hallmark properties of
cancer (Kavanagh and Joseph, 2011). As demonstrated by the aforementioned findings, we
see a need for deeper validation of these pathways to illuminate nuances and understand the
tumor etiology.
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6 Concluding remarks
In this work, we take a post-selective approach to integrative Bayesian modeling of high
dimensional data. Integrative investigations of complex data across different modes of infor-
mation have the potential to identify biological underpinnings and reveal their relationships
with patient outcomes in several disease domains. In the specific context of cancer, associ-
ations between genomics and radiomics collectively throw light on how these inter-related
features correlate with clinically relevant endpoints and inform models with better prog-
nostic abilities. Nonetheless integrative analyses face many key barriers from an analytical
standpoint. One, existing structure within the high dimensional covariate space– commonly
dubbed as sparsity– must be harnessed effectively for scalable and reproducible modeling.
Two, reliable estimates of effect sizes for the potential discoveries must be calibrated using
the often scarce set of matched samples along the multiple modalities. These settings include
samples which were utilized for model search in the mining stages, thereby introducing the
problem of selection-bias during inference. Three, existing domain knowledge must be incor-
porated into inference to lend biological insights into the models and the findings associated
with them.
We address the above challenges through a posterior which is defined after regularized
model search leveraging intermediary phenotypes. Yet our posterior is crafted to account
precisely for the data driven nature of the integrative model. Faced with the lack of com-
pact analytic expressions for the corrected form of the posterior, we provide formulae that a
general class of samplers can utilize for uncertainty estimation. The two ingredients in our
methods are a simplified conditional likelihood and a transformation of parameter space. The
results applied to model links between gene pathways and patient outcomes using associa-
tions with the radiomic phenotypes are quite promising in both statistical and computational
terms. Adaptive models with fewer parameters no doubt lead to more scalable and easy to
interpret findings. In reusing these samples, we showcase a unique and effective partitioning
of our available data for modeling and follow-up inference through a conditional perspec-
tive after selection. Detailed comparisons with splitting at different resolutions particularly
highlight how our proposal fares in this inevitable tradeoff in data.
We conclude by remarking that there is certainly room for future directions. We hope
that the scalability of our data adaptive methods will accommodate complicated joint mod-
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els involving both radiomic and genomic features. Relating the clinical outcomes to the
various radiogenomic markers in such models will possibly throw new light on how these
features interact together to impact the underlying response. Further, a framework to bor-
row structure shared between the different radiomic measurements will prompt use of other
structure inducing penalties distinct from an `1-type regularization. Devising post-selective
Bayesian methods which adapt to these sparsities will assume natural relevance in these
scenarios. With this work as a first attempt at exploring post-selective inferential techniques
in the domain of high dimensional integrative Bayesian modeling, we leave these problems
for interesting future explorations.
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8 Appendix
A Proofs of results
Proof. First we observe that the (unconditional) likelihood (Y, I,R) under a fixed predictor
regression framework is proportional to
exp(−(Y −GE¯βE¯)T (Y −GE¯βE¯)/2σ2) · exp(−RTR/2η2)
× exp
(
−
n∑
i=1
(Ii − µ(αF¯ ))TΣ−1I (Ii − µ(αF¯ ))/2
)
(15)
assuming the models (5) and (6), but ignoring the adaptive nature of the model; where
Ii =
(
Ii,1 · · · Ii,L
)
, and µ(αF¯ ) =
(
G1;F1αF1 · · · Gi;FLαFL
)
.
In the above unconditional likelihood, we use the independence between the outcome,
the intermediary variables and the randomization variable introduced in model selection.
Truncating (15) to the selection event leading to variable sets F̂l(Il, G) = Fl for 1 ≤ l ≤ L
and Ê(Y,R;GF¯ ) = E yields a joint conditional likelihood, which is proportional to:
exp(−(Y −GE¯βE¯)T (Y −GE¯βE¯)/2σ2) · exp(−RTR/2η2)
× exp
(
−
n∑
i=1
(Ii − µ(αF¯ ))TΣ−1I (Ii − µ(αF¯ ))/2
)
· 1{Fˆl(Il;G)=Fl,1≤l≤L}1{Eˆ(Y,R;GF¯ )=E}.
Finally, marginalizing over the intermediary variables and the randomization variable gives
rise to the normalizing constant
P[Eˆ(Y,R;GF¯ ) = E | βE¯]× P[Fˆl(Il;G) = Fl for l = 1, 2, · · · , L | αF1 , · · · , αFL ].
Notice that the probability over the intermediary and primary outcome variables decouples,
again due to the independence assumption between the errors in (6). Ignoring the functions
involving the auxiliary parameters
αF1 , · · · , αFL
in the resulting likelihood, we note that the conditional likelihood contributing to the pos-
terior for β¯E now equals
exp(−(β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2) ·
{
P[Ê(Y,R;GF¯ ) = E | βE¯]
}−1
.
This matches with the expression in Proposition 1.
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Proof. To see a proof for Proposition 2, selection of active variables E with signs sE is
equivalent to (10). Using the stationary map (9) for realizations (y, r) and based upon the
decomposition GT
F¯
y = GT
F¯
GE¯β̂E¯ + β̂
⊥, we first note that the sign constraints are equivalent
to
diag(sE)(G
T
EGE + I)
−1(rE +GTEGE¯β̂E¯ + β̂
⊥
E − ΛEsE) > 0.
Next, we note that the inactive coordinates of the stationary map yield the equality:
rEc +G
T
EcGE¯β̂E¯ + β̂
⊥
Ec −GTEcGEβ̂ LASSOE = ΛEcz.
Coupled with the equation
β̂ LASSOE = (G
T
EGE + I)
−1(rE +GTEGE¯β̂E¯ + β̂
⊥ − ΛEsE),
the restriction on the `∞-norm of inactive subgradient vector z is equivalent to the constraints
rEc −GTEcGE(GTEGE + I)−1rE +
(
GTEcGE¯ −GTEcGE(GTEGE + I)−1GTEGE¯
)
β̂E¯
+ β̂⊥Ec −GTEcGE(GTEGE + I)−1β̂⊥E > −λEc −GTEcGE(GTEGE + I)−1ΛEsE,
and
− rEc +GTEcGE(GTEGE + I)−1rE −
(
GTEcGE¯ −GTEcGE(GTEGE + I)−1GTEGE¯
)
β̂E¯
− β̂⊥Ec +GTEcGE(GTEGE + I)−1β̂⊥E > −λEc +GTEcGE(GTEGE + I)−1ΛEsE.
The union of polytopes now follows from considering all possible signs for the active coeffi-
cients, which varies over the set {−1, 1}|E|.
Proof. To derive an expression for the conditional likelihood, we use a change of measure
map from R → (β̂E¯, β̂⊥, β̂ LASSOE , z) where β̂ LASSOE and z are obtained from the stationary
conditions of the randomized LASSO at the solution
R = −GTF¯GE¯β̂E¯ +
GTEGE + I
GTEcGE
 β̂ LASSOE + (−β̂⊥ + (ΛEsE,ΛEcz)T )
= −GTF¯GE¯β̂E¯ +Q · β̂ LASSOE + s(β̂⊥, sE, z);
s(β̂⊥, sE, z−E) = (ΛEsE,ΛEcz)T − β̂⊥ and Q =
GTEGE + I
GTEcGE
. Noting that the Jacobian of
the above change of variables map dissolves as a constant, the density of (β̂E¯, β̂
LASSO
E ) when
conditioned upon
{Eˆ = E, sign(β̂ LASSOE ) = sE, z = zobs, β̂⊥ = βˆ⊥,obs}
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is proportional to
exp(−(β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2)
× exp
(
− (−GTF¯GE¯β̂E¯ +Q · β̂ LASSOE + s(βˆ⊥,obs, sE, zobs))T
(−GTF¯GE¯β̂E¯ +Q · β̂ LASSOE + s(βˆ⊥,obs, sE, zobs))/2η2
)
· 1{sign(β̂ LASSOE )=sE}.
Equivalently, the above density is proportional to
exp(−(β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2)
× exp(−(β̂ LASSOE − p(β̂E¯))TQTQ(β̂ LASSOE − p(β̂E¯))/2η2) · 1{sign(β̂ LASSOE )=sE},
(16)
where p(b) = (QTQ)−1QT
(
GT
F¯
GE¯b+ βˆ
⊥,obs − (ΛEsE,ΛEczobs)T
)
.
Letting b represent the variable β̂E¯ and w represent β̂
LASSO
E and integrating over the support
of this joint density (16)
{(b, w) : sign(w) = sE},
the normalizing constant for this density now equals:∫
sign(w)=sE
(2pi)−|E¯|/2 · det(ΣE¯)−1/2 · exp(−(b− βE¯)TΣ−1E¯ (b− βE¯)/2)
(2pi)−|E|/2 · det(QTQ/η2)1/2 exp(−(w − p(b))TQTQ(w − p(b))/2η2)dwdb.
This completes the derivation of the conditional likelihood.
Proof. First, we compute the Jacobian associated with the transformation of parameters.
This is given by the derivative of the map Ψ with respect to ζE¯. We observe that
J (ζE¯) = ∂Ψ(ζE¯)/∂ζE¯ =
(
I + η−2ΣE¯P
TQTQP
)
− η−2ΣE¯P TQTQ · ∂(w∗(ζE¯))/∂ζE¯.
(17)
From the definition of w∗(ζE¯), we see that it satisfies the estimating equation:
η−2QTQ (w∗(ζE¯)− PζE¯ − o) +∇CsE(w∗(ζE¯)) = 0.
Taking a derivative with respect to ζE¯ we have:(
η−2QTQ+∇2CsE(w∗(ζE¯))
)
∂(w∗(ζE¯))/∂ζE¯ = η
−2QTQP.
This implies
∂(w∗(ζE¯))/∂ζE¯ =
(
η−2QTQ+∇2CsE(w∗(ζE¯))
)−1
η−2QTQP,
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and plugged into (17), the Jacobian equals:(
I + η−2ΣE¯P
TQTQP
)− η−4ΣE¯P TQTQ (η−2QTQ+∇2CsE(w∗(ζE¯)))−1QTQP.
To obtain an expression for the log-posterior, we use the change of measure βE¯ → ζE¯
formula in (12) to obtain an expression for the selection-corrected posterior
pi(ζE¯|β̂E¯) = |J (ζE¯)| · pi(Ψ(ζE¯)|β̂E¯).
Ignoring the normalizing constant, log pi(ζE¯|β̂E¯) equals
log |J (ζE¯)|+ log pi(Ψ(ζE¯)) + β̂TE¯Σ−1E¯ Ψ(ζE¯)−Ψ(ζE¯)TΣ−1E¯ Ψ(ζE¯)/2
+ inf
b,w
{
(b−Ψ(ζE¯))TΣ−1E¯ (b−Ψ(ζE¯))/2 + (w − p(b))TQTQ(w − p(b))/2η2
+ CsE(w)
}
.
= log |J (ζE¯)|+ log pi(Ψ(ζE¯)) + β̂TE¯Σ−1E¯ Ψ(ζE¯)
− b∗TΣ−1
E¯
Ψ(ζE¯) + b
∗TΣ−1
E¯
b∗/2 + (w∗ − p(b∗))TQTQ(w∗ − p(b∗))/2η2 + CsE(w∗);
(18)
where b∗, w∗ are the optimal solutions for the optimization:
inf
b,w
{
(b−Ψ(ζE¯))TΣ−1E¯ (b−Ψ(ζE¯))/2 + (w − p(b))TQTQ(w − p(b))/2η2 + CsE(w)
}
.
Finally, we note that
Ψ(ζE¯) = b
∗ + η−2ΣE¯
(
∂
∂b
w∗(b)
∣∣∣
b∗
− P
)T
QTQ(w∗(b∗)− p(b∗))
+ ΣE¯
(
∂
∂b
w∗(b)
∣∣∣
b∗
)T
∇CsE(w∗(b))
= b∗ − η−2ΣE¯P TQTQ(w∗(b∗)− p(b∗))
= b∗ + η−2ΣE¯P
TQTQPb∗ + η−2ΣE¯P
TQTQ(o− w∗(b∗));
where the second equality follows from the optimality conditions for w∗
η−2QTQ(w∗(b∗)− p(b∗)) +∇CsE(w∗(b∗)) = 0.
Finally, from the definition of Ψ(ζE¯), it follows that b
∗ = ζE¯ and thus follows from (18)
that log pi(ζE¯|β̂E¯) (ignoring constants) equals
log |J (ζE¯)|+ log pi(Ψ(ζE¯)) + β̂TE¯Σ−1E¯ Ψ(ζE¯)− ζTE¯Σ−1E¯ Ψ(ζE¯)
+ ζTE¯Σ
−1
E¯
ζE¯/2 + inf
w
{
(w − PζE¯ − o)TQTQ(w − PζE¯ − o)/2η2 + CsE(w)
}
.
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Proof. From the expression of the transformed posterior in Theorem 2, the gradient of
log pi(ζE¯|β̂E¯) is computed as follows. Observing
η−2QTQ (w∗(ζE¯)− PζE¯ − o) +∇CsE(w∗(ζE¯)) = 0,
we have ∇ log pi(ζE¯|β̂E¯) equals
∇ log |det(J (ζE¯))|+ (J (ζE¯))T ·
(
∇ log pi(Ψ(ζE¯)) + Σ−1E¯ β̂E¯ − Σ−1E¯ ζE¯
)
− Σ−1
E¯
·Ψ(ζE¯) + Σ−1E¯ ζE¯ − P TQTQ(w∗(ζE¯)− P · ζE¯ − o)/η2
= ∇ log |det(J (ζE¯))|+ (J (ζE¯))T
(
∇ log pi(Ψ(ζE¯)) + Σ−1E¯ β̂E¯ − Σ−1E¯ ζE¯
)
.
The last equality follows from the definition of the reparameterization map (13).
Recall that
J (ζE¯) =
(
I + η−2ΣE¯P
TQTQP
)
− η−4ΣE¯P TQTQ
(
η−2QTQ+∇2CsE(w∗(ζE¯))
)−1
QTQP.
Let the j-th column of the matrix
∂(w∗(ζE¯))/∂ζE¯ =
(
η−2QTQ+∇2CsE(w∗(ζE¯))
)−1
η−2QTQP
be Jj. Before computing the derivative, we make the observation that this matrix is positive
definite. This follows directly by representing the Jacobian matrix as follows:
ΣE¯ ·
(
Σ−1
E¯
+ η−2P TQT
[
I − η−2Q(∇2CsE)−1/2(η−2(∇2CsE)−1/2QTQ
(∇2CsE)−1/2 + I)−1(∇2CsE)−1/2QT
]
QP
)
= ΣE¯ ·
(
Σ−1
E¯
+ η−2P TQT (I + η−2Q(∇2CsE)−1QT )−1QP
)
.
The proof is complete by calculating ∇ log |det(J (ζE¯))|, whose j-th coordinate equals:
Trace
(
− η−4J −1(ζE¯)ΣE¯P TQTQ ·
∂
∂ζj,E¯
(N−1)QTQP
)
= Trace
(
η−4J −1(ζE¯)ΣE¯P TQTQN−1
(
∂
∂ζj,E¯
(N(ζE¯))
)
N−1QTQP
)
= Trace
(
η−4J −1(ζE¯)ΣE¯P TQTQN−1
(
C˜sE(w
∗(ζE¯)) · diag(Jj)
)
N−1QTQP
)
,
where the l-th diagonal entry of C˜sE(w
∗(ζE¯)) equals ∇3Bl(w∗) and diag(Jj) is a diagonal
matrix with the vector Jj along the diagonal.
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B Supplementary details on approximate posterior
Below, we provide details on the expression of the approximate posterior in (12) in the main
manuscript. For the sake of completeness, we include the motivation behind the approxima-
tion as a finite-sample upper bound on the selection probability.
Proposition 3. Under the modeling assumptions 5 and 6 and a convex, compact region K,
the selection probability
P
[
(β̂E¯, β̂
LASSO
E ) ∈ K | βE¯
]
≤ (2pi)−|E¯|/2 · det(ΣE¯)−1/2
× exp
(
− inf
(b,w)∈K
{
(b− βE¯)TΣ−1E¯ (b− βE¯)/2 + (w − p(b))TQTQ(w − p(b))/2η2
})
,
where p(·) and Q are defined in Theorem 1.
Proof. Denoting the MGF of the random variables (β̂E¯, β̂
LASSO
E ) at (η1, η2) as Λ(η1, η2) with
respect to their density before selection (see Theorem 1)
(2pi)−|E¯|/2 · det(ΣE¯)−1/2 · exp(−(β̂E¯ − βE¯)TΣ−1E¯ (β̂E¯ − βE¯)/2)
× exp(−(β̂ LASSOE − p(β̂E¯))TQTQ(β̂ LASSOE − p(β̂E¯))/2η2),
observe that:
logP
[
(β̂E¯, β̂
LASSO
E ) ∈ K | βE¯
]
≤ logE
[
exp
(
ηT1 β̂E¯ + η
T
2 β̂
LASSO
E − inf
(b,w)∈K
{ηT1 b+ ηT2 w}
) ∣∣∣ βE¯ ]
= sup
(b,w)∈K
−ηT1 b− ηT2 w + log Λ(η1, η2).
Since the above inequality holds for any η1, η2, optimizing over the parameters η1, η2 and
using a minimax equality for a convex and compact subset K yields the following bound on
the log-selection probability (ignoring constants):
− sup
η1,η2
inf
(b,w)∈K
{
ηT1 b+ η
T
2 w − log Λ(η1, η2)
}
= − inf
(b,w)∈K
sup
η1,η2
{
ηT1 b+ η
T
2 w − log Λ(η1, η2)
}
= − inf
(b,w)∈K
{
(b− βE¯)TΣ−1E¯ (b− βE¯)/2
+ (w − p(b))TQTQ(w − p(b))/2η2
}
.
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The selection probability in Theorem 1 is calculated over the region {(b, w) : sign(w) =
sE}, which is convex but not compact. Yet, the approximate posterior obtained by appending
a prior to the conditional likelihood and plugging in the bound in Proposition 3 works
well under the assumption that we can consider a large enough compact subset K ′ of the
region: {(b, w) : sign(w) = sE} for all βE¯ in a bounded set of probability close to 1 under
pi(·). Rigorous asymptotic justification of the approximate selection-corrected posterior for
non-Gaussian data is based on guarantees aligned along the moderate deviations scale in
(Panigrahi et al., 2016); we refer interested readers to this previous work for more details on
this topic.
C Radiogenomic feature construction: details
Below, we include details on the construction of gene pathway scores and radiomic measure-
ments which we use for radiogenomic modeling and inference.
C.1 Pathway scores
Pathway based methods provide significant benefits by offering interpretability, as gene func-
tions are exerted collectively and may vary based on several factors such as genetic modi-
fication, disease state, or environmental stimuli. Using pathways provides an intuitive way
and a stable context for assessing the biological activity (Ha¨nzelmann et al., 2013). Pathway
scores are computed using the gene-set variation analysis (GSVA), which estimates a value
per sample for the variation of pathway activity within an entire gene expression set, using
a non-paramteric and unsupervised approach (Ha¨nzelmann et al., 2013). In other words, a
pathway score assesses the relative variability of gene expression of the genes in the pathway
as compared to expression of genes not in the pathway. We give a brief overview of the
analytical procedure for GSVA next.
Let Z be the p×n matrix of normalized gene expression values corresponding to p genes
and n samples (p  n). Let G = {g1, . . . , gm} represent a collection of pathways (also
referred to as gene-sets). Each pathway gk is defined as gk ⊂ {1, . . . , p} with |gk| denoting
its cardinality. Let the expression profile for the gene i be given as zi = (zi1, . . . , zin).
Firstly, in the context of the sample population distribution GSVA evaluates whether a
gene i is highly or lowly expressed in the sample j. To compare distinct expression profiles on
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the same scale, an expression-level statistic is computed. A non-parametric kernel estimation
of the cumulative density function is performed for each zi using a Gaussian kernel, that is,
we compute Fˆsi(zij) =
1
n
n∑
r=1
Φ(
zij−zir
si
). Here si is the gene-specific bandwidth parameter
controlling the resolution of the kernel estimation. These statistics Fˆsi(zij) are converted to
ranks r(i)j for each sample j. The ranks r(i)j are normalized further as tij = |p2 − r(i)j| so that
the tails of the rank distribution are up-weighted while computing the enrichment score. The
normalized ranks tij are used to compute a Kolmogorov-Smirnov (KS) type random walk
statistic for l = 1, . . . , p as
ηjk(l) =
l∑
i=1
|tij|τI(u(i) ∈ gk)
p∑
i=1
|tij|τI(u(i) ∈ gk)
−
l∑
i=1
I(u(i) ∈ gk)
p− |gk| .
Here I(u(i) ∈ gk) is an indicator taking the value 1 if the gene corresponding to the rank i
expression level statistic belongs to the pathway gk and τ is the parameter describing the
weight of the tail. By identifying if the genes in a pathway are more likely to belong to
either tail of the rank distribution, the statistic ηjk(l) produces a distribution over the genes.
The enrichment score for the pathway gk and the sample j is constructed by converting the
corresponding KS-like statistic as Sjk = max
l
(0, ηjk(l))−min
l
(0, ηjk(l)). Sjk has a clear bio-
logical interpretation as it emphasizes genes in pathways that are concordantly activated in
one direction only, which are either over-expressed or under-expressed relative to the overall
population (Ha¨nzelmann et al., 2013). Low enrichment is shown for pathways containing
genes strongly acting in both directions. The computations are performed using the GSVA
package in R obtained from the Bioconductor package (Gentleman et al., 2004) under the
default settings for the choice of parameters.
C.2 MRI scans and radiomic phenotypes
We consider four types of MRI sequences which include (i) native (T1), (ii) post-contrast
T1-weighted (T1Gd), (iii) T2-weighted (T2), and (iv) T2 fluid attenuated inversion recovery
(FLAIR) volumes. Each of these sequences display different types of tissues with varying
contrasts based on the tissue characteristics. Note that the whole brain MRI scans are three
dimensional objects and have an array structure. In Figure 5, we show an axial slice from the
MRI scan of a LGG subject corresponding to all four imaging sequences with the segmented
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tumor region indicated by a (red) boundary overlaid on those images. This tumor region is
further classified into sub-regions (NC, ED and ET) by GLISTRboost as shown in Figure 5.
Voxel-level features are usually extracted to provide additional insight into the tumor
physiology, and have been studied in the context of the progression (or regression) of tu-
mors. Summary statistics such as percentiles, quartiles, skewness, kurtosis etc., are evaluated
to represent a region of interest and are used as features/covariates in downstream analysis
(Baek et al., 2012; Just, 2014; Song et al., 2013). However, some of their drawbacks include
the subjectivity in the choice of number and location of summary features, and limitations
in terms of capturing entire information from the histogram of intensity values. To ad-
dress this, we consider the smoothed density arising from the voxel-level intensity histogram
which incorporates granular characteristics of tumor heterogeneity (Saha et al., 2016). The
variability in these intensity histograms across the subjects is captured through the scores
from a principal component analysis on the space of density functions using a Reimannian-
geometric framework. In other words, these principal component scores obtained from the
density functions act as the radiomic phenotypes which capture the heterogeneity in the
tumor voxels from the MRI scans. We include these details in Sections C.2 and C.3.
C.3 Principal Component Scores
Next, we discuss the construction of the principal component scores when we have prob-
ability density functions (pdfs) as data objects corresponding to n samples. Without loss
of generality, let us consider densities on [0, 1] and let F denote the Banach manifold of
such pdfs defined as F = {f : [0, 1] → R+|
∫ 1
0
f(x)dx = 1}. A non-parametric Fisher-Rao
Reimannian metric which is invariant to reparameterizations can be defined, however it is
computationally challenging to compute the geodesic paths and distances using this metric
(Srivastava and Klassen, 2016).
An equivalent representation of the space F via the square-root transformation (SRT)
representation (Bhattacharyya, 1943) simplifies computations. The SRT is defined as a
function h = +
√
f (we omit the + sign hereafter for notational convenience). Also, the
inverse mapping is unique and is simply given by f = h2 (Kurtek and Bharath, 2015). Space
of SRTs is given by H = {h : [0, 1] → R+| ∫ 1
0
h(x)2dx = 1} and represents the postive
orthant of a unit Hilbert sphere (Lang, 2012). The L2 Riemmanian metric on H can be
defined as 〈〈δh1, δh2〉〉 =
∫ 1
0
δh1(t)δh2(t)dt, where δh1, δh2 ∈ Th(H) and Th(H) = {δh :
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[0, 1] → R| ∫ 1
0
h(x)δh(x)dx = 0}. The geodesic paths and lengths can now be analytically
computed due to the Reimannian geometry of H equipped with the L2 metric. The geodesic
distance between h1, h2 ∈ H is simply given by d(h1, h2) = θ = cos−1
( ∫ 1
0
h1(x)h2(x)dx
)
.
The geometry of the space of SRTs can be used to define an average (or mean) density
corresponding to a sample of density functions. This allows us to efficiently summarize
and visualize a sample of densities. The average pdf can be computed using a generalized
version of mean on a metric space called the Karcher mean (Karcher, 1977). Suppose we
have n pdfs f1, . . . , fn and the corresponding SRTs as h1, . . . , hn. The sample Karcher mean
h¯ on H is defined as the minimizer of the Karcher variance ρ(h¯) =
n∑
i=1
d(hi, h¯)
2
L2 , that is,
h¯ = argminh∈Hd(hi, h¯)
2
L2 . Algorithm 1 presents a gradient-based approach to compute the
Karcher mean on H (Dryden and Mardia, 1998).
Algorithm 1 Sample Karcher mean of densities
1: h¯0 (initial estimate for the Karcher mean) ← any one of the densities in the sample OR
the extrinsic average. Set j ← 0 and 1, 2 > 0 be small.
2: For i = 1, . . . , n compute ui = exp
−1
h¯j
(hi).
3: Compute the average direction in the tangent space u¯ = 1
n
∑n
i=1 ui.
4: if ||u¯||L2 < 1 then
5: return h¯j as the Karcher mean.
6: else
7: h¯j+1 = exph¯j(2u¯).
8: Set j ← j + 1.
9: Return to step 2.
Note that the Karcher mean of the sample pdfs is an intrinsic average that is computed
directly on H (or equivalently F). Hence we have a mean which is an actual pdf (Karcher
mean) and a distance function. Here the inverse exponential map, denoted by exp−1h1 :
H 7→ Th1(H), is given by exp−1h1 (h2) = (θ/ sin(θ))(h2 − h1 cos(θ)). The exponential map at
a point h1 ∈ H, denoted by exp : Th1(H) 7→ H, is defined as exph1(δh) = cos(‖δh‖)h1 +
sin(‖δh‖)(δh/‖δh‖), where ‖δh‖ = ( ∫ 1
0
δh(x)2dx
)1/2
.
Under the standard settings, visualizing the space of pdfs intuitively is not straight
forward. Principal component analysis (PCA) is an effective method to explore the variability
in the pdfs through their primary modes of variation in the data. Note that the tangent
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space is a vector space (Euclidean), hence PCA can be implemented, as in standard problems.
Algorithm 2 describes the computation of PCA on the space generated by the pdfs f1, . . . , fn
and the corresponding SRTs h1, . . . , hn.
Algorithm 2 PCA on P
1: Compute the Karcher mean of h1, . . . , hn as h¯.
2: for i = 1, . . . , n do
3: Compute projections (vi = exp
−1
h¯
(hi)) of hi onto Th¯(H).
4: Evaluate sample covariance matrix K = 1
n−1
n∑
i=1
viv
>
i ∈ Rm×m.
5: Compute the SVD of K = UΣU>.
Note that the first r columns of U (denoted as U˜ ∈ Rm×r) span the r-dimensional
principal subspace. We can compute the principal coefficients as X = V U˜ , where V > =
[v1 v2 . . . vn] ∈ Rm×n. These principal coefficients X (principal component scores) act
as Euclidean coordinates corresponding to densities fi and can be used as predictors for
downstream modeling.
In Figure 7, we represent the workflow to construct the principal component scores using
the tumor intensity values for the T1 MRI sequence. The same workflow is followed for
the other three MRI sequences to compute the principal component scores. The number of
principal components to include could be chosen using a threshold on the percent variance
explained.
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Figure 7: Workflow to obtain the principal component scores from the tumor sub-regions
(ND, ET, and ED) in the T1 MRI scan.
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